11 hedge funds and large institutions have $2.46M invested in BiomX in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
2
Closed
2
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
-$17K
Name Market Value Shares Shares
Change
Shares
Change %
JJ
1
Johnson & Johnson
New Jersey
$1.56M 2,133,402
MI
2
MMCAP International
Cayman Islands
$500K 684,451
RA
3
Royce & Associates
New York
$240K 328,655 +8,000 +2%
Millennium Management
4
Millennium Management
New York
$58K 78,933 -18,422 -19%
BCM
5
Bridgeway Capital Management
Texas
$43K 58,700
Renaissance Technologies
6
Renaissance Technologies
New York
$31K 42,200 +18,300 +77%
Jane Street
7
Jane Street
New York
$16K 22,462 -2,522 -10%
UBS Group
8
UBS Group
Switzerland
$8K 10,608 +9,158 +632%
BlackRock
9
BlackRock
New York
$4K 5,750
O
10
OrbiMed
New York
$2.05K 2,813,489
KC
11
Kepos Capital
New York
-450,597 Closed
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
-605 Closed
Bank of America
13
Bank of America
North Carolina
$0 2
JGC
14
J. Goldman & Co
New York
CFGS
15
Concourse Financial Group Securities
Alabama